Connection
Marco De Dominici to Imatinib Mesylate
This is a "connection" page, showing publications Marco De Dominici has written about Imatinib Mesylate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.034 |
|
|
|
-
Riva B, De Dominici M, Gnemmi I, Mariani SA, Minassi A, Minieri V, Salomoni P, Canonico PL, Genazzani AA, Calabretta B, Condorelli F. Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of ?-catenin and mTORC1/2. Oncotarget. 2016 Dec 06; 7(49):81555-81570.
Score: 0.034